These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 29489494)

  • 21. Efficacy and Safety of Basimglurant as Adjunctive Therapy for Major Depression: A Randomized Clinical Trial.
    Quiroz JA; Tamburri P; Deptula D; Banken L; Beyer U; Rabbia M; Parkar N; Fontoura P; Santarelli L
    JAMA Psychiatry; 2016 Jul; 73(7):675-84. PubMed ID: 27304433
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hypericum extract in patients with MDD and reversed vegetative signs: re-analysis from data of a double-blind, randomized trial of hypericum extract, fluoxetine, and placebo.
    Murck H; Fava M; Alpert J; Nierenberg AA; Mischoulon D; Otto MW; Zajecka J; Mannel M; Rosenbaum JF
    Int J Neuropsychopharmacol; 2005 Jun; 8(2):215-21. PubMed ID: 15458612
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Single i.v. ketamine augmentation of newly initiated escitalopram for major depression: results from a randomized, placebo-controlled 4-week study.
    Hu YD; Xiang YT; Fang JX; Zu S; Sha S; Shi H; Ungvari GS; Correll CU; Chiu HF; Xue Y; Tian TF; Wu AS; Ma X; Wang G
    Psychol Med; 2016 Feb; 46(3):623-35. PubMed ID: 26478208
    [TBL] [Abstract][Full Text] [Related]  

  • 24. St John's wort extract (LI 160) in somatoform disorders: results of a placebo-controlled trial.
    Volz HP; Murck H; Kasper S; Möller HJ
    Psychopharmacology (Berl); 2002 Nov; 164(3):294-300. PubMed ID: 12424553
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Efficacy and tolerability of the novel triple reuptake inhibitor amitifadine in the treatment of patients with major depressive disorder: a randomized, double-blind, placebo-controlled trial.
    Tran P; Skolnick P; Czobor P; Huang NY; Bradshaw M; McKinney A; Fava M
    J Psychiatr Res; 2012 Jan; 46(1):64-71. PubMed ID: 21925682
    [TBL] [Abstract][Full Text] [Related]  

  • 26. B vitamins to enhance treatment response to antidepressants in middle-aged and older adults: results from the B-VITAGE randomised, double-blind, placebo-controlled trial.
    Almeida OP; Ford AH; Hirani V; Singh V; vanBockxmeer FM; McCaul K; Flicker L
    Br J Psychiatry; 2014 Dec; 205(6):450-7. PubMed ID: 25257064
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Curcumin and major depression: a randomised, double-blind, placebo-controlled trial investigating the potential of peripheral biomarkers to predict treatment response and antidepressant mechanisms of change.
    Lopresti AL; Maes M; Meddens MJ; Maker GL; Arnoldussen E; Drummond PD
    Eur Neuropsychopharmacol; 2015 Jan; 25(1):38-50. PubMed ID: 25523883
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Chronic Supplementation of Curcumin Enhances the Efficacy of Antidepressants in Major Depressive Disorder: A Randomized, Double-Blind, Placebo-Controlled Pilot Study.
    Yu JJ; Pei LB; Zhang Y; Wen ZY; Yang JL
    J Clin Psychopharmacol; 2015 Aug; 35(4):406-10. PubMed ID: 26066335
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Metyrapone as additive treatment in major depression: a double-blind and placebo-controlled trial.
    Jahn H; Schick M; Kiefer F; Kellner M; Yassouridis A; Wiedemann K
    Arch Gen Psychiatry; 2004 Dec; 61(12):1235-44. PubMed ID: 15583115
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Desvenlafaxine 50 and 100 mg/d in the treatment of major depressive disorder: an 8-week, phase III, multicenter, randomized, double-blind, placebo-controlled, parallel-group trial and a post hoc pooled analysis of three studies.
    Tourian KA; Padmanabhan SK; Groark J; Brisard C; Farrington D
    Clin Ther; 2009 Jun; 31 Pt 1():1405-23. PubMed ID: 19698901
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A Randomized, Double-Blind, Placebo-Controlled, Sequential Parallel Comparison Design Trial of Adjunctive Riluzole for Treatment-Resistant Major Depressive Disorder.
    Mathew SJ; Gueorguieva R; Brandt C; Fava M; Sanacora G
    Neuropsychopharmacology; 2017 Dec; 42(13):2567-2574. PubMed ID: 28553836
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Add-on Treatment with Curcumin Has Antidepressive Effects in Thai Patients with Major Depression: Results of a Randomized Double-Blind Placebo-Controlled Study.
    Kanchanatawan B; Tangwongchai S; Sughondhabhirom A; Suppapitiporn S; Hemrunrojn S; Carvalho AF; Maes M
    Neurotox Res; 2018 Apr; 33(3):621-633. PubMed ID: 29327213
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Parallel-group placebo-controlled trial of testosterone gel in men with major depressive disorder displaying an incomplete response to standard antidepressant treatment.
    Pope HG; Amiaz R; Brennan BP; Orr G; Weiser M; Kelly JF; Kanayama G; Siegel A; Hudson JI; Seidman SN
    J Clin Psychopharmacol; 2010 Apr; 30(2):126-34. PubMed ID: 20520285
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Economic evaluation of St. John's wort (Hypericum perforatum) for the treatment of mild to moderate depression.
    Solomon D; Adams J; Graves N
    J Affect Disord; 2013 Jun; 148(2-3):228-34. PubMed ID: 23291009
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mineralocorticoid receptor function in depressed patients and healthy individuals.
    Hinkelmann K; Hellmann-Regen J; Wingenfeld K; Kuehl LK; Mews M; Fleischer J; Heuser I; Otte C
    Prog Neuropsychopharmacol Biol Psychiatry; 2016 Nov; 71():183-8. PubMed ID: 27519144
    [TBL] [Abstract][Full Text] [Related]  

  • 36. St. John's wort - an overview.
    Linde K
    Forsch Komplementmed; 2009 Jun; 16(3):146-55. PubMed ID: 19657198
    [TBL] [Abstract][Full Text] [Related]  

  • 37. St John's wort for depression.
    Linde K; Mulrow CD
    Cochrane Database Syst Rev; 2000; (2):CD000448. PubMed ID: 10796719
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pharmacokinetic interaction of digoxin with an herbal extract from St John's wort (Hypericum perforatum).
    Johne A; Brockmöller J; Bauer S; Maurer A; Langheinrich M; Roots I
    Clin Pharmacol Ther; 1999 Oct; 66(4):338-45. PubMed ID: 10546917
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cognitive function in older adults with major depression: Effects of mineralocorticoid receptor stimulation.
    Otte C; Wingenfeld K; Kuehl LK; Richter S; Regen F; Piber D; Hinkelmann K
    J Psychiatr Res; 2015 Oct; 69():120-5. PubMed ID: 26343603
    [TBL] [Abstract][Full Text] [Related]  

  • 40. An open-label pilot study of St. John's wort in juvenile depression.
    Findling RL; McNamara NK; O'Riordan MA; Reed MD; Demeter CA; Branicky LA; Blumer JL
    J Am Acad Child Adolesc Psychiatry; 2003 Aug; 42(8):908-14. PubMed ID: 12874492
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.